2023


  1. Göbel P, Kuba K, Götze H, Mehnert-Theuerkauf A, Spitzer C, Hartung T, Esser P (2023). Interconnectivity of fear of progression and generalized anxiety - Network analysis among a sample of hematological cancer survivors. Support Care Cancer, 31(4), 238.
     
  2. Hartung TJ, Friedrich M, Esser P, Mehnert-Theuerkauf A, Lehmann-Laue A, Letsch A, Rose M, Fendel U (2023). The German version of the body image scale: Validation and item response analysis in cancer patients. J Psychosom Res, 165, 111129.
     


    3. 2022


  3. Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, Haeusler KG, Heuschmann PU, Hildesheim H, Hinz A, Hopff S, Horn A, Krawczak M, Krist L, Kudelka J, Lieb W, Maetzler C, Mehnert-Theuerkauf A, Montellano FA, Morbach C, Schmidt S, Schreiber S, Steigerwald F, Störk S, Maetzler W, Finke C (2022). Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine, 53, 101651.
     


    4. 2021


  4. Gebhardt C, Mehnert-Theuerkauf A, Hartung T, Zimmermann A, Glaesmer H, Götze H (2021). COMSKIL: Ein Lehrkonzept zur Gesprächsführung im Humanmedizinstudium. / COMSKIL: A communication skills training program for medical students. GMS Journal for Medical Education, 38(4), Doc83.
     
  5. Hartung TJ, Moustsen IR, Larsen SB, Wreford Andersen EA, Suppli NP, Johansen C, Tjønneland A, Friberg AS, Kjær SK, Brasso K, Kessing LV, Mehnert A, Dalton SO (2021). Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners. J Cancer Surviv, 15(4), 536-545.
     
  6. Schulte T, Hofmeister D, Mehnert-Theuerkauf A, Hartung T, Hinz A (2021). Assessment of sleep problems with the Insomnia Severity Index (ISI) and the sleep item of the Patient Health Questionnaire (PHQ-9) in cancer patients. Support Care Cancer, 29(12), 7377-7384.
     
  7. Koranyi S, Hinz A, Hufeld JM, Hartung TJ, Quintero Garzón L, Fendel U, Letsch A, Rose M, Esser P, Mehnert-Theuerkauf A (2021). Psychometric Evaluation of the Germany Version of the Demoralization Scale-II and the Association Between Demoralization, Sociodemographic, Disease- and Treatment-Related Factors in Patients with Cancer. Front. Psychol., 12, 789793.
     


    8. 2020


  8. Esser P, Mehnert-Theuerkauf A, Friedrich M, Johansen C, Brähler E, Faller H, Härter M, Koch U, Schulz H, Wegscheider K, Weis J, Kuba K, Hinz A, Hartung T (2020). Risk and associated factors of depression and anxiety in men with prostate cancer: Results from a German multicenter study. Psychooncology, 29, 1604-1612.
     


    9. 2019


  9. Hartung TJ, Fried EI, Mehnert A, Hinz A, Vehling S (2019). Frequency and network analysis of depressive symptoms in patients with cancer compared to the general population. J Affect Disord, 256, 295-301.
     
  10. Esser P, Metelmann M, Hartung T, Claßen J, Mehnert A, Koranyi S (2019). Psychosoziale Versorgung bei Patienten mit Amyotropher Lateralsklerose: Ein narrativer Review. Psychother Psychosom Med Psychol, 69, 372-381.
     


    11. 2018


  11. Hartung TJ, Sautier LP, Scherwath A, Sturm K, Kröger N, Koch U, Mehnert A (2018). Return to Work in Patients with Hematological Cancers 1 Year after Treatment: A Prospective Longitudinal Study. Oncol Res Treat, 41, 697-701.
     
  12. Esser P, Hartung TJ, Friedrich M, Johansen C, Wittchen HU, Faller H, Koch U, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Mehnert A (2018). The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients. Psycho-Oncology, 27(6), 1509-1516.
     
  13. Hartung TJ, Kissane D, Mehnert A (2018). COMSKIL Communication Training in Oncology-Adaptation to German Cancer Care Settings. Recent Results Cancer Res, 210, 191-205.
     
  14. Mehnert A, Hartung TJ, Friedrich M, Vehling S, Brähler E, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Koch U, Faller H (2018). One in two cancer patients is significantly distressed: Prevalence and indicators of distress. Psycho-Oncology, 27(1), 75-82.
     


    15. 2017


  15. Hartung TJ, Friedrich M, Johansen C, Wittchen HU, Faller H, Koch U, Brähler E, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Mehnert A (2017). The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Cancer, 123(21), 4236-4243.
     
  16. Vehling S, Kissane DW, Lo C, Glaesmer H, Hartung TJ, Rodin G, Mehnert A (2017). The association of demoralization with mental disorders and suicidal ideation in patients with cancer. Cancer, 123(17), 3394-3401.
     
  17. Mehnert A, Barth J, Gaspar M, Leibbrand B, Kegel CD, Bootsveld W, Friedrich M, Hartung TJ, Berger D, Koch U (2017). Predictors of early retirement after cancer Rehabilitation - a longitudinal study. Eur J Cancer Care, 26(5), e12528.
     
  18. Hartung TJ, Brähler E, Faller H, Härter M, Hinz A, Johansen C, Keller M, Koch U, Schulz H, Weis J, Mehnert A (2017). The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer, 72, 46-53.
     
  19. Hartung TJ, Johansen C (2017). Sozioökonomischer Status und Krebs. FORUM, 32(4), 318-323.
     


    20. 2016


  20. Engelmann D, Scheffold K, Friedrich M, Hartung TJ, Schulz-Kindermann F, Lordick F, Schilling G, Lo C, Rodin G, Mehnert A (2016). Death-Related Anxiety in Patients With Advanced Cancer: Validation of the German Version of the Death and Dying Distress Scale. J Pain Symptom Manage, 52, 582-587.
     
  21. Hartung TJ, Mehnert A, Friedrich M, Hartmann M, Vehling S, Bokemeyer C, Oechsle K (2016). Age-related variation and predictors of long-term quality of life in germ cell tumor survivors. Urol Oncol, 34(2), 60.e1-60.e6.
     


    22. 2015


  22. Mehnert A, Hartung TJ (2015). Psychoonkologische Versorgungsforschung. Nervenarzt, 86(3), 258-265.